Work

Rethinking cancer clinical trial eligibility—Inclusion is a scientific and moral imperative

Year: 2025

Type: article

Abstract: Cancer clinical trials remain essential to advancing oncology but suffer from persistent disparities because of restrictive eligibility criteria, implicit bias, and social determinants of health that disproportionately exclude racial minorities, women, and underserved populations. Applying a socioecological framework and reforming trial design—through relaxed criteria, targeted recruitment, and systemic support—can significantly improve equity and inclusivity in cancer research.

Source: Cancer

DOI: 10.1002/cncr.70182

Author: Nupur Mittal

Institution: Rush University Medical Center

Language: English

Topic: Ethics in Clinical Research

Subfield: Public Health, Environmental and Occupational Health

Field: Medicine

Domain: Health Sciences

SDGs: Reduced inequalities, Good health and well-being

Open Access status: hybrid

Estimated APC paid: $4,790